Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/10/2010US20100143462 New carbamazephine formulations having inproved solubility
06/10/2010US20100143461 Palonosetron formulation
06/10/2010US20100143460 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
06/10/2010US20100143459 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
06/10/2010US20100143456 Model membrane systems
06/10/2010US20100143454 Flavivirus NS5A Proteins For the Treatment of HIV
06/10/2010US20100143453 Anti-inflammatory compounds containing compositions for treatment of cancer
06/10/2010US20100143452 Polyphenol containing compositions
06/10/2010US20100143451 Composition for Improving Skin Condition and Appearance
06/10/2010US20100143450 DEVELOPMENT OF ASTHMA THERAPY WITH rAAV-mediated AMCase shRNA
06/10/2010US20100143449 Analgesic composition of topically applied nonsteroidal antiinflammatory drugs and opioids
06/10/2010US20100143446 Novel skin moisturizing compositions
06/10/2010US20100143441 Nortriptyline compounds for promoting bone growth
06/10/2010US20100143440 Ul97 inhibitors for treatment of proliferative disorders
06/10/2010US20100143424 Casein nanoparticle
06/10/2010US20100143420 Multi-phasic pharmaceutical formulations of poorly water-soluble drugs for reduced fed/fasted variability and improved oral bioavailability
06/10/2010US20100143419 Storage of Ampoules Containing Pharmaceutical Formulations Using a Sealed Container Comprising an Oxygen Scavenger
06/10/2010US20100143416 Alpha-defensins as anthrax immunotherapeutis
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143409 Generation of virus-like particles and use as panfilovirus vaccines
06/10/2010US20100143404 Thiophene derivatives for up-regulating HLA-DM activity
06/10/2010US20100143398 Synergistic Phytoceutical Compositions
06/10/2010US20100143387 Multimeric conjugate
06/10/2010US20100143386 FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs
06/10/2010US20100143384 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/10/2010US20100143382 Modulation of rhamm (cd168) for selective adipose tissue development
06/10/2010US20100143381 Lysophosphatidic acid receptor targeting for lung disease
06/10/2010US20100143379 Mif agonists and antagonist and therapeutic uses thereof
06/10/2010US20100143375 Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
06/10/2010US20100143371 Intrabodies
06/10/2010US20100143366 Antitumor agent
06/10/2010US20100143363 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
06/10/2010US20100143361 Methods for the treatment of a-beta related disorders and compositions therefor
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143359 Expression of foxp3 by cancer cells
06/10/2010US20100143357 Uses of Mammalian Cytokine; Related Reagents
06/10/2010US20100143355 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
06/10/2010US20100143354 Triazine dna modifiers
06/10/2010US20100143350 Combination of a purine-based cdk inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
06/10/2010US20100143347 Targeting ncca-atp channel for organ protection following ischemic episode
06/10/2010US20100143346 Treatment of Macular Degeneration
06/10/2010US20100143344 Complement inhibition for improved nerve regeneration
06/10/2010US20100143343 Methods and compositions for the treatment of antibody mediated neuropathies
06/10/2010US20100143341 Thienopyrimidines for pharmaceutical compositions
06/10/2010US20100143338 Treatment of t-cell mediated diseases
06/10/2010US20100143333 Method of treating diabetes
06/10/2010US20100143332 Combination therapy for proliferative disorders
06/10/2010US20100143330 Methods of treating disorders associated with fat storage
06/10/2010US20100143324 Method for treatment of cancers or inflammatory diseases
06/10/2010US20100143322 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease
06/10/2010US20100143318 Gstp1 as teratogenic allele for autism and assays and methods based thereon
06/10/2010US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
06/10/2010US20100143308 Akt nucleic acids, polypeptides, and uses thereof
06/10/2010US20100143304 Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
06/10/2010US20100143301 Modulators of toll-like receptors
06/10/2010US20100143300 Hepatitis c therapies
06/10/2010US20100143299 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
06/10/2010US20100143298 Colloidal metal compositions and methods
06/10/2010US20100143297 Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density
06/10/2010US20100143296 Podophyllotoxin inhibitors of topoisomerase ii
06/10/2010US20100143295 Quinazoline inhibitors of egfr tyrosine kinase
06/10/2010US20100143289 Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
06/10/2010US20100143287 Trifluoromethylphenyl modulators of calcium-sensing receptor
06/10/2010US20100143286 Preparation of functional gel particles with a dual crosslink network
06/10/2010US20100143285 Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer
06/10/2010US20100143284 Water-In-Oil Type Emulsion Composition
06/10/2010US20100143279 Cosmetic/dermatological compositions comprising a derivative of glucose and of vitamin f and a specific surfactant
06/10/2010US20100143270 Therapeutic cotinine compositions
06/10/2010US20100143269 Pharmaceutical compositions for the treatment of asthma
06/10/2010US20100143253 Compounds and amyloid probes thereof for therapeutic and imaging uses
06/10/2010US20100143251 Compounds and amyloid probes thereof for therapeutic and imaging uses
06/10/2010US20100143243 Frozen compositions and methods for piercing a substrate
06/10/2010US20100143242 Delivery system for therapy comprising hollow seeds, and the method of use thereof
06/10/2010US20100140131 Production of an Oxaliplatin Mixture and a Container and a Container Set for Said Mixture
06/10/2010DE102008061214A1 Chinazolinamidderivate Chinazolinamidderivate
06/10/2010DE102008060967A1 Substituierte Phenylsulfonyltriazolone und ihre Verwendung Substituted Phenylsulfonyltriazolone and their use
06/10/2010DE102008060203A1 Sheet-like device, useful for transdermal administration of e.g. rotigotine to treat Parkinson's disease, comprises an active ingredient containing layer, an active agent impermeable backing layer and a removable protective layer
06/10/2010DE102008059578A1 Benzo-Naphtyridin Verbindungen Benzo-naphtyridine connections
06/10/2010DE102008059206A1 Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum A pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
06/10/2010DE102008051140B4 Verfahren zur Herstellung eines einphasischen pharmazeutischen Präparates zur Begrenzung/Minderung des Risikos einer Tiefen-Venen-Thrombose in Einheit mit einer oralen Kontrazeption Process for the preparation of a pharmaceutical preparation einphasischen to limit / reduce the risk of deep vein thrombosis in unity with oral contraception
06/10/2010DE102005054610B4 Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung Flupirtine-containing pharmaceutical composition with controlled drug release
06/10/2010CA2782525A1 Pharmaceutical compositions containing testosterone and an aromatase inhibitor
06/10/2010CA2750577A1 Inhibitors of hcv ns5a
06/10/2010CA2746004A1 Inhibitors of hcv ns5a
06/10/2010CA2746003A1 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
06/10/2010CA2746001A1 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
06/10/2010CA2745919A1 Compositions and methods relating to mir-31
06/10/2010CA2745832A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
06/10/2010CA2745811A1 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
06/10/2010CA2745799A1 Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits
06/10/2010CA2745795A1 Compositions for potentiating apoposis signals in tumour cells
06/10/2010CA2745774A1 Combination of lycopene, polyphenol, and vitamins for the care of keratin material
06/10/2010CA2745746A1 Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer
06/10/2010CA2745741A1 Zaleplon gastroretentive drug delivery system
06/10/2010CA2745721A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
06/10/2010CA2745715A1 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
06/10/2010CA2745690A1 Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative
06/10/2010CA2745598A1 Fully human influenza m2 specific antibodies
06/10/2010CA2745579A1 Thick pine needle extract composition for capsulation
06/10/2010CA2745525A1 Oral dosage forms of bendamustine
1 ... 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 ... 7860